COVID-19 & Flu A+B

Combined testing for COVID-19, Flu A & Flu B** is here!

BD Veritor™ Plus System

BD Veritor COVID-19 and Flu A+B Assay

SARS-CoV-2 & Influenza A+B rapid antigen testing

1 sample. 1 test. 3 unambiguous results.

BD, working with clinicians and diagnostic experts, has developed a new assay that allows you to provide reliable, rapid point-of-care testing and results for SARS-CoV-2 and Influenza A and B from the same patient sample.

Is it Flu or is it COVID-19?
You need answers you can trust.

Symptoms for common respiratory conditions including COVID-19 and influenza are nearly identical. So when patients present with these symptoms, the treatment imperative will be to quickly and reliably diagnose these patients to manage to the treatment pathway AND isolation measures required.

icon array explaining symptoms and testing

Get more answers
with every sample

You get easy-to-read digital results for COVID-19 and Flu A+B in just 15 minutes:1

  • FLU A Results: "FLU A: +" for positive, "Flu A: -" for negative
  • FLU B Results: ”FLU B:+” for positive, “FLU B:-“ for negative
  • SARS-CoV-2 Results: "CoV2: +" for positive, "CoV2: -" for negative


And the BD Veritor™ Plus System provides clear, trusted and unambiguous results by detecting positives not recognized by the unaided eye.1

BD Veritor Plus Analyzer

Available now!

BD Veritor COVID-19 and Flu A+B kit

**The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 & Flu A+B is intended for the qualitative detection of SARS-CoV-2 and/or influenza A and B nucleocapsid antigens directly from anterior nasal swab samples taken from individuals who are suspected of a viral respiratory infection consistent with  COVID-19 by a healthcare provider, within the first six days of symptom onset

•This test has been authorized for sale in Canada by Health Canada under Interim Order.

•This test is only authorized for the duration of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, unless the authorization is terminated or revoked sooner.

•This test has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens.